Published on Apr 27, 2016
April 27 — Bill Ackman, Pershing Square Capital Management’s chief executive officer, speaks at a Senate hearing on Valeant and drug pricing. Pershing Square has investments in Valeant.
Bill Ackman Talks To Congress About Valeant
Updated on
